Kourosh Rezania

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

Petra Kaufmann, John L.P. Thompson, Gilberto Levy et al. · Annals of Neurology · 2009 · 233 citations · Full text

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis

James D. Berry, Jeremy M. Shefner, Robin Conwit et al. · PLoS ONE · 2013 · 101 citations · Full text

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

Richard AC Hughes, Marinos C. Dalakas, Ingemar S. J. Merkies et al. · The Lancet Neurology · 2018 · 69 citations · Full text

Rheumatology, Oral Fingolimod, Ophthalmology +10

A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset, incomplete penetrance and a sensory neuropathy

Kourosh Rezania, Jianhua Yan, Lisa Dellefave et al. · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · 2003 · 43 citations